A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
NCT07758634
This study is recruiting at 7 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
A Study of CTX340 in Participants with Uncontrolled Hypertension.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hypertension
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- CRISPR Therapeutics AG
- Last updated on ClinicalTrials.gov
- November 12, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 3
- Flourish Research - Jacksonville · Jacksonville, FL
- Flourish Research - Orlando · Orlando, FL
- United Medical Research (Progressive Research) · Port Orange, FL
New York · 1
- University of Rochester · Rochester, NY
North Carolina · 2
- Duke · Durham, NC
- Peters Medical Research · High Point, NC
Oregon · 1
- Oregon Health & Science University (OHSU) · Portland, OR
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.